These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Minors come of age: Minor histocompatibility antigens and graft-versus-host disease. Chao NJ Biol Blood Marrow Transplant; 2004 Apr; 10(4):215-23. PubMed ID: 15077220 [TBL] [Abstract][Full Text] [Related]
26. HLA control in the progression of human papillomavirus infections. Breitburd F; Ramoz N; Salmon J; Orth G Semin Cancer Biol; 1996 Dec; 7(6):359-71. PubMed ID: 9284528 [TBL] [Abstract][Full Text] [Related]
27. HLA-G proteins in cancer: do they provide tumor cells with an escape mechanism? Rouas-Freiss N; Moreau P; Ferrone S; Carosella ED Cancer Res; 2005 Nov; 65(22):10139-44. PubMed ID: 16287995 [TBL] [Abstract][Full Text] [Related]
28. Identification of mycobacterial peptide epitopes recognized by CD4+ T cells in association with multiple major histocompatibility complex class II molecules. Mustafa AS Nutrition; 1995; 11(5 Suppl):657-60. PubMed ID: 8748245 [TBL] [Abstract][Full Text] [Related]
29. Invariant chain association with MHC class I: preference for HLA class I/beta 2-microglobulin heterodimers, specificity, and influence of the MHC peptide-binding groove. Vigna JL; Smith KD; Lutz CT J Immunol; 1996 Nov; 157(10):4503-10. PubMed ID: 8906828 [TBL] [Abstract][Full Text] [Related]
30. HLA-G in human reproduction: aspects of genetics, function and pregnancy complications. Hviid TV Hum Reprod Update; 2006; 12(3):209-32. PubMed ID: 16280356 [TBL] [Abstract][Full Text] [Related]
31. Antigen unfolding and disulfide reduction in antigen presenting cells. Jensen PE Semin Immunol; 1995 Dec; 7(6):347-53. PubMed ID: 8775460 [TBL] [Abstract][Full Text] [Related]
32. [Genetic polymorphisms, function and clinical effect of HLA-G]. Meng H; Hou Y Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Aug; 19(4):350-3. PubMed ID: 12170478 [TBL] [Abstract][Full Text] [Related]
33. Genetic insights into disease mechanisms of autoimmunity. Simmonds MJ; Gough SC Br Med Bull; 2004; 71():93-113. PubMed ID: 15701924 [TBL] [Abstract][Full Text] [Related]
34. The exogenous pathway for antigen presentation on major histocompatibility complex class II and CD1 molecules. Watts C Nat Immunol; 2004 Jul; 5(7):685-92. PubMed ID: 15224094 [TBL] [Abstract][Full Text] [Related]
35. Monocyte-derived HLA-G acts as a strong inhibitor of autologous CD4 T cell activation and is upregulated by interferon-beta in vitro and in vivo: rationale for the therapy of multiple sclerosis. Mitsdoerffer M; Schreiner B; Kieseier BC; Neuhaus O; Dichgans J; Hartung HP; Weller M; Wiendl H J Neuroimmunol; 2005 Feb; 159(1-2):155-64. PubMed ID: 15652415 [TBL] [Abstract][Full Text] [Related]
36. Bidirectional blockade of CD4 and major histocompatibility complex class II molecules: an effective immunosuppressive treatment in the mouse heart transplantation model. Ito H; Hamano K; Fukumoto T; Wood KJ; Esato K J Heart Lung Transplant; 1998 May; 17(5):460-9. PubMed ID: 9628564 [TBL] [Abstract][Full Text] [Related]
37. HLA, salivary IgA and mutans streptococci--is there a relation? Wallengren ML Swed Dent J Suppl; 2004; (166):1-67. PubMed ID: 15224545 [TBL] [Abstract][Full Text] [Related]
38. Cell-surface expression and alloantigenic function of a human nonclassical class I molecule (HLA-E) in transgenic mice. Pacasova R; Martinozzi S; Boulouis HJ; Ulbrecht M; Vieville JC; Sigaux F; Weiss EH; Pla M J Immunol; 1999 May; 162(9):5190-6. PubMed ID: 10227992 [TBL] [Abstract][Full Text] [Related]
39. The intracellular assembly of antigenic-peptide-class II complexes. Pierce SK; Green JM; Faassen AE; Xu X; Song W; Cho H; Schafer P; Psaradellis T; Wagle N; Kim J Biomed Pept Proteins Nucleic Acids; 1995; 1(3):149-56. PubMed ID: 9346846 [TBL] [Abstract][Full Text] [Related]